Re: The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma
Affiliation:
1. EA4466 – PRETRAM, Faculty of Pharmacy, Paris Descartes University, Sorbonne Paris Cité, Paris, France;2. Clinical Chemistry Department, Hôpitaux Universitaires Paris Centre, AP-HP, Paris, France